Bio Key International (BKYI) EBIAT (2016 - 2025)
Bio Key International's EBIAT history spans 16 years, with the latest figure at -$964849.0 for Q3 2025.
- For Q3 2025, EBIAT fell 30.57% year-over-year to -$964849.0; the TTM value through Sep 2025 reached -$4.3 million, up 19.58%, while the annual FY2024 figure was -$4.3 million, 49.53% up from the prior year.
- EBIAT for Q3 2025 was -$964849.0 at Bio Key International, up from -$1.2 million in the prior quarter.
- Across five years, EBIAT topped out at -$510285.0 in Q1 2024 and bottomed at -$6.8 million in Q4 2022.
- The 5-year median for EBIAT is -$1.4 million (2024), against an average of -$1.7 million.
- The largest annual shift saw EBIAT surged 74.74% in 2021 before it tumbled 234.6% in 2022.
- A 5-year view of EBIAT shows it stood at -$2.0 million in 2021, then crashed by 234.6% to -$6.8 million in 2022, then soared by 65.05% to -$2.4 million in 2023, then skyrocketed by 41.65% to -$1.4 million in 2024, then soared by 30.31% to -$964849.0 in 2025.
- Per Business Quant, the three most recent readings for BKYI's EBIAT are -$964849.0 (Q3 2025), -$1.2 million (Q2 2025), and -$736545.0 (Q1 2025).